192 Mucosal disease

Saturday, March 24, 2012: 9:45 a.m.-11 a.m.
Session Type: Poster Session
1.25 CE hours

Learning Objectives:
n/a
RASDX: Standardized diagnostic criteria for recurrent aphthous stomatitis.        
L. BACCAGLINI1, J.J. SHUSTER2, D.W. THERIAQUE3, G. SERRANO1, and R. LALLA4, 1Community Dentistry and Behavioral Science, College of Dentistry, University of Florida, Gainesville, FL, 2Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL, 3Regulatory Knowledge and Research Support, Clinical & Translational Science Institute, University of Florida, Gainesville, FL, 4Section of Oral Medicine, University of Connecticut Health Center, Farmington, CT
Patient-reported risk factors for recurrent aphthous stomatitis (RAS)
G. SERRANO1, R. LALLA2, J.J. SHUSTER3, D.W. THERIAQUE4, and L. BACCAGLINI1, 1Community Dentistry and Behavioral Science, College of Dentistry, University of Florida, Gainesville, FL, 2Section of Oral Medicine, University of Connecticut Health Center, University of Connecticut, Farmington, CT, 3Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL, 4Regulatory Knowledge and Research Support, Clinical & Translational Science Institute, University of Florida, Gainesville, FL
High Sugar Consumption in Recurrent Aphthous Stomatitis
A. NGUYEN, University of Florida, Gainesville, FL, D.W. THERIAQUE, Clinical & Translational Science Institute, University of Florida, Gainesville, FL, J.J. SHUSTER, Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL, and L. BACCAGLINI, Community Dentistry and Behavioral Science, University of Florida, Gainesville, FL
Oral Graft-versus-Host Disease: Clinical Presentation, Predictive Factors and Significance
H. FASSIL1, C. BASSIM2, D. EDWARDS3, K. BAIRD4, S.M. STEINBERG5, S. MITCHELL6, L. GRKOVIC1, D. ZHANG5, and S. PAVLETIC1, 1Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, MD, 2National Institute for Dental Craniofacial Research, NIH, Bethesda, MD, 3National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, 4Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, 5Center for Cancer Research, Biostatistics and Data Management Section, National Cancer Institute, NIH, Bethesda, MD, 6Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD
Local Delivery of Imiquimod to Buccal Mucosa
S.K. RAMINENI, University of Kentucky, Lexington, KY, D. PULEO, Center for Biomedical Engineering, University of Kentucky, Lexington, KY, and L. CUNNINGHAM, Oral Health Science, University of Kentucky, Lexington, KY
PEDF functions as an endogenous anti-angiogenic during dermal wound repair
M.S. WIETECHA, M.J. KRÓL, and L.A. DIPIETRO, Center for Wound Healing and Tissue Regeneration, University of Illinois - Chicago, Chicago, IL
LED is better than LASER for Chemotherapy-induced Oral Mucositis
L. CAMPOS1, A.C.C. FREITAS1, M. MARQUES2, M. CRISTOFARO3, C.P. EDUARDO2, and A. SIMOES1, 1Dental Materials, University of Sao Paulo, Sao Paulo, Brazil, 2Restorative Dentistry, University of Sao Paulo, Sao Paulo, Brazil, 3Oral Pathology, University of Sao Paulo, Sao Paulo, Brazil
Double-blinded chemoprevention trial: berry gel shows efficacy relative to placebo
M. TONG1, B. HAN1, W. CHEN2, Y. LING2, Z. LIU2, A. CURRAN3, B.S. SHUMWAY4, G. KUSHNER5, G. BLAKEY III6, P. PEI1, G. STONER7, P. LARSEN2, and S. MALLERY1, 1College of Dentistry, Ohio State University, Columbus, OH, 2Ohio State University, Columbus, OH, 3School of Dentistry, University of North Carolina, Chapel Hill, NC, 4Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 5Oral and Maxillofacial Surgery, University of Louisville, Louisville, KY, 6Oral & Maxillofacial Surgery, University of North Carolina, Chapel Hill, NC, 7Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
NOS2 Induction by Human Beta Defensin 3 (hBD3) in Macrophages
J. JUN, Case Western Reserve University, Cleveland, OH